← All stocks

Pharvaris N.V.

PHVS Scheduled selling only
CIK 0001830487 #1865 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$5.88M
$327.73K on a plan · $5.55M straight out of an exercise
Sold at will
$0.00
0 of 10 sales
Net
−$5.88M
$0.00 against sales at will

By person

11 insiders · 10 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Abele Stefan Andreas
Chief Technical Ops Officer
$1.77M (2) scheduled
−$1.77M
39,068
0.0599%
$1.50M
−20.6%
Lu Peng
President
$1.21M (2) scheduled
−$1.21M
64,953
0.0996%
$2.49M
−2.0%
Lesage Anne
Chief Early Development
$1.15M (1) scheduled
−$1.15M
150,419
0.2307%
$5.76M
−31.8%
Souverijns Wim
Chief Commercial Officer
$1.02M (2) scheduled
−$1.02M
39,021
0.0598%
$1.49M
−29.2%
Glassman Robert
Director
$632.11K (2) scheduled
−$632.11K
10,500
0.0161%
$401.87K
−30.8%
Modig Berndt
Chief Executive Officer
$90.28K (1) scheduled
−$90.28K
1,078,334
1.65%
$41.27M
−3.3%
Schikan Johannes Gerardus Christiaan Petrus
Director
315,167
0.4833%
$12.06M
−20.2%
Nassif David W.
CFO / CLO
120,300
0.1845%
$4.60M
−7.7%
Nijdam Anna
Principal Accounting Officer
46,275
0.0710%
$1.77M
−10.7%
Bjork Elisabeth
Director
15,167
0.0233%
$580.49K
0.0%
Monges Viviane
Director
5,500
0.0084%
$210.50K
−63.7%
Insider
Date
Role
Action
Shares
Price
Amount
Souverijns Wim
15 Sep 2026
Chief Commercial Officer
Sold on a plan
6,090
$38.99
$237.45K
Modig Berndt
14 Sep 2026
Chief Executive Officer
Sold on a plan
2,291
$39.40
$90.28K

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 8
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 141,893
History held since 3 Apr 2026